Annals of Oncology

1

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma

Hohaus, S, Giachelia, M, Di Febo, A, Martini, M, Massini, G, Vannata, B, D'Alo', F, Guidi, F, Greco, M, Pierconti, F, Larocca, L., Voso, M., Leone, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 127 KB

english, 2007

2

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

Beauclair, S, Formento, P, Fischel, J., Lescaut, W, Largillier, R, Chamorey, E, Hofman, P, Ferrero, J., Pages, G, Milano, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 418 KB

english, 2007

3

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy

El Gnaoui, T, Dupuis, J, Belhadj, K, Jais, J-P, Rahmouni, A, Copie-Bergman, C, Gaillard, I, Divine, M, Tabah-Fisch, I, Reyes, F, Haioun, C

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 90 KB

english, 2007

4

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

Zervas, K, Mihou, D, Katodritou, E, Pouli, A, Mitsouli, C., Anagnostopoulos, A, Delibasi, S, Kyrtsonis, M., Anagnostopoulos, N, Terpos, E, Zikos, P, Maniatis, A, Dimopoulos, M.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 122 KB

english, 2007

5

in this issue

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 28 KB

english, 2007

6

Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004

Arbyn, M, Autier, P, Ferlay, J

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 564 KB

english, 2007

7

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon- 2b in patients with multiple myeloma maintained on a steady dose of interferon- 2b

Sirohi, B, Powles, R, Lawrence, D, Treleaven, J, Kulkarni, S, Leary, A, Rudin, C, Horton, C, Morgan, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 98 KB

english, 2007

8

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

De Vita, F, Giuliani, F, Orditura, M, Maiello, E, Galizia, G, Di Martino, N, Montemurro, F, Carteni, G, Manzione, L, Romito, S, Gebbia, V, Ciardiello, F, Catalano, G, Colucci, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 109 KB

english, 2007

9

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Carles, J, Esteban, E, Climent, M, Font, A, Gonzalez-Larriba, J., Berrocal, A, Garcia-Ribas, I, Marfa, X, Fabregat, X, Albanell, J, Bellmunt, J

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 75 KB

english, 2007

10

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells

Farace, F, Massard, C, Borghi, E, Bidart, J-M, Soria, J-C

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 177 KB

english, 2007

11

Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study

Travier, N, Jeffreys, M, Brewer, N, Wright, C., Cunningham, C., Hornell, J, Pearce, N

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 80 KB

english, 2007

12

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling

Beeram, M, Tan, Q-T., Tekmal, R., Russell, D, Middleton, A, deGraffenried, L.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 316 KB

english, 2007

13

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type

Kim, S., Kim, B., Choi, C., Choi, J, Kim, I, Lee, Y-H, Kim, J.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 226 KB

english, 2007

14

Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution

Gentilini, O, Botteri, E, Rotmensz, N, Intra, M, Gatti, G, Silva, L, Peradze, N, Sahium, R., Gil, L., Luini, A, Veronesi, P, Galimberti, V, Gandini, S, Goldhirsh, A, Veronesi, U

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 108 KB

english, 2007

15

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer

Klaeser, B, Wiederkehr, O, Koeberle, D, Mueller, A, Bubeck, B, Thuerlimann, B

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 80 KB

english, 2007

16

Prognosis for long-term survivors of cancer

Janssen-Heijnen, M., Houterman, S, Lemmens, V., Brenner, H, Steyerberg, E., Coebergh, J.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 500 KB

english, 2007

17

The other side of p53

Ferretti, G, Felici, A, Cognetti, F

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 30 KB

english, 2007

18

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations

Launay-Vacher, V, Chatelut, E, Lichtman, S., Wildiers, H, Steer, C, Aapro, M

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 115 KB

english, 2007

19

The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study

Kelly, L, White, S, Stone, P.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 85 KB

english, 2007

20

Breast cancer prognostication and prediction in the postgenomic era

Lonning, P., Knappskog, S, Staalesen, V, Chrisanthar, R, Lillehaug, J.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 842 KB

english, 2007

21

Assessment of the biological and pharmacological effects of the 3 and 5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors

Hariharan, S, Gustafson, D, Holden, S, McConkey, D, Davis, D, Morrow, M, Basche, M, Gore, L, Zang, C, O'Bryant, C., Baron, A, Gallemann, D, Colevas, D, Eckhardt, S.

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 270 KB

english, 2007

22

Endocrine resistance in breast cancer: what really matters?

Dawood, S, Cristofanilli, M

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 47 KB

english, 2007

23

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

Ferrandina, G, Ludovisi, M, De Vincenzo, R, Salutari, V, Lorusso, D, Colangelo, M, Prantera, T, Valerio, M., Scambia, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 87 KB

english, 2007

24

Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?

Torresin, A, Feasi, M, Cassola, G

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 33 KB

english, 2007

25

Volume 18; Issue 8

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

in this issue

Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon- 2b in patients with multiple myeloma maintained on a steady dose of interferon- 2b

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells

Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type

Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer

Prognosis for long-term survivors of cancer

The other side of p53

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations

The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study

Breast cancer prognostication and prediction in the postgenomic era

Assessment of the biological and pharmacological effects of the 3 and 5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors

Endocrine resistance in breast cancer: what really matters?

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?

Table of Contents